期刊
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
卷 44, 期 9, 页码 1588-1601出版社
SPRINGER
DOI: 10.1007/s00259-017-3728-y
关键词
Neuroendocrine tumours; Neuroendocrine neoplasms; Pet/Ct; Ga-68-DOTATATE; Ga-68-DOTATOC; Ga-68-DOTANOC; F-18-DOPA; F-18-FDG; Thyroid medullary cancer; Pheochromoacytoma; Paraganglioma; Foregut-NET; Midgut-NET; Hindgut-NET; Hyperinsulism in infants
资金
- Novo Nordisk Fonden [NNF15OC0017912] Funding Source: researchfish
- The Danish Cancer Society [R146-A9491] Funding Source: researchfish
Purpose & Methods Neuroendocrine neoplasms are a heterogenous group of tumours, for which nuclear medicine plays an important role in the diagnostic work-up as well as in the targeted therapeutic options. This guideline is aimed to assist nuclear medicine physicians in recommending, performing, reporting and interpreting the results of somatostatin receptor (SSTR) PET/CT imaging using Ga-68-DOTA-conjugated peptides, as well as F-18-DOPA imaging for various neuroendocrine neoplasms. Results & Conclusion The previous procedural guideline by EANM regarding the use PET/CT tumour imaging with Ga-68-conjugated peptides has been revised and updated with the relevant and recent literature in the field with contribution of distinguished experts.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据